74 related articles for article (PubMed ID: 20132187)
21. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR).
Kim JS; Lee SH; Cho YS; Choi JJ; Kim YH; Lee JH
Gynecol Oncol; 2002 May; 85(2):260-5. PubMed ID: 11972385
[TBL] [Abstract][Full Text] [Related]
23. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
24. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions.
Konarska L; Skierski J; Ellert A; Steinbrich J; Woźniak A; Kalczak M
Acta Biochim Pol; 2001; 48(3):783-93. PubMed ID: 11833787
[TBL] [Abstract][Full Text] [Related]
26. Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia.
Anders M; Rösch T; Küster K; Becker I; Höfler H; Stein HJ; Meining A; Wiedenmann B; Sarbia M
Cancer Gene Ther; 2009 Jun; 16(6):508-15. PubMed ID: 19132065
[TBL] [Abstract][Full Text] [Related]
27. CD82, and CD63 in thyroid cancer.
Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C
Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577
[TBL] [Abstract][Full Text] [Related]
28. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases].
Janser JC; Pusel J; Rodier JF; Navarrete E; Rodier D
J Chir (Paris); 1989 Nov; 126(11):619-24. PubMed ID: 2685000
[TBL] [Abstract][Full Text] [Related]
29. Coxsackievirus and adenovirus receptor (CAR)-positive immature osteoblasts as targets of adenovirus-mediated gene transfer for fracture healing.
Ito T; Tokunaga K; Maruyama H; Kawashima H; Kitahara H; Horikoshi T; Ogose A; Hotta Y; Kuwano R; Katagiri H; Endo N
Gene Ther; 2003 Sep; 10(18):1623-8. PubMed ID: 12907955
[TBL] [Abstract][Full Text] [Related]
30. [Immunohistochemical study in differential diagnosis of benign and malignant lesions of the thyroid gland].
Kazantseva IA; Fedosenko AK; Gurevich LE
Arkh Patol; 2001; 63(4):18-21. PubMed ID: 11534185
[TBL] [Abstract][Full Text] [Related]
31. uPA receptor expression in benign and malignant thyroid tumors.
Kim SJ; Shiba E; Taguchi T; Tsukamoto F; Miyoshi Y; Tanji Y; Takai S; Noguchi S
Anticancer Res; 2002; 22(1A):387-93. PubMed ID: 12017319
[TBL] [Abstract][Full Text] [Related]
32. Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid.
Nasir A; Catalano E; Calafati S; Cantor A; Kaiser HE; Coppola D
In Vivo; 2004; 18(2):189-95. PubMed ID: 15113046
[TBL] [Abstract][Full Text] [Related]
33. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
[TBL] [Abstract][Full Text] [Related]
35. Coxsackievirus and adenovirus receptor expression in human endometrial adenocarcinoma: possible clinical implications.
Giaginis CT; Zarros AC; Papaefthymiou MA; Papadopouli AE; Sfiniadakis IK; Theocharis SE
World J Surg Oncol; 2008 Jun; 6():59. PubMed ID: 18558015
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification.
Kholová I; Ludvíková M; Ryska A; Hanzelková Z; Cap J; Pecen L; Topolcan O
Neoplasma; 2003; 50(3):159-64. PubMed ID: 12937847
[TBL] [Abstract][Full Text] [Related]
37. Human herpes simplex viruses in benign and malignant thyroid tumours.
Jensen K; Patel A; Larin A; Hoperia V; Saji M; Bauer A; Yim K; Hemming V; Vasko V
J Pathol; 2010 Jun; 221(2):193-200. PubMed ID: 20455254
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors.
Kholová I; Ludvíkova M; Ryska A; Topolcan O; Pikner R; Pecen L; Cáp J; Holubec L
Anticancer Res; 2003; 23(2A):871-5. PubMed ID: 12820316
[TBL] [Abstract][Full Text] [Related]
39. Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression.
You Z; Fischer DC; Tong X; Hasenburg A; Aguilar-Cordova E; Kieback DG
Cancer Gene Ther; 2001 Mar; 8(3):168-75. PubMed ID: 11332987
[TBL] [Abstract][Full Text] [Related]
40. Coxsackie adenovirus receptor expression in carcinomas of the head and neck.
Wunder T; Schumacher U; Friedrich RE
Anticancer Res; 2012 Mar; 32(3):1057-62. PubMed ID: 22399632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]